MARC details
| 000 -LEADER |
|---|
| fixed length control field |
06239nam a2200613 i 4500 |
| 001 - CONTROL NUMBER |
|---|
| control field |
BDZ0016926574 |
| 003 - CONTROL NUMBER IDENTIFIER |
|---|
| control field |
StDuBDS |
| 005 - DATE AND TIME OF LATEST TRANSACTION |
|---|
| control field |
20180923150110.0 |
| 008 - FIXED-LENGTH DATA ELEMENTS--GENERAL INFORMATION |
|---|
| fixed length control field |
120214s2013 paua f 001|0|eng|d |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781451175721 (hbk.) : |
| Terms of availability |
£52.00 |
| 020 ## - INTERNATIONAL STANDARD BOOK NUMBER |
|---|
| International Standard Book Number |
9781451175721 (hardback) : |
| Terms of availability |
Đ52.00 |
| 040 ## - CATALOGING SOURCE |
|---|
| Original cataloging agency |
StDuBDS |
| Language of cataloging |
eng |
| Transcribing agency |
StDuBDS |
| Modifying agency |
StDuBDSZ |
| Description conventions |
rda |
| 042 ## - AUTHENTICATION CODE |
|---|
| Authentication code |
ukblsr |
| 050 #0 - LIBRARY OF CONGRESS CALL NUMBER |
|---|
| Classification number |
RS403 |
| Item number |
.P75 2013 |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
HEA |
| Source |
ukslc |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
MKG |
| Source |
thema |
| 072 #7 - SUBJECT CATEGORY CODE |
|---|
| Subject category code |
TDCW |
| Source |
thema |
| 082 0# - DEWEY DECIMAL CLASSIFICATION NUMBER |
|---|
| Classification number |
616.0756 FOY |
| 130 0# - MAIN ENTRY--UNIFORM TITLE |
|---|
| Uniform title |
Principles of medicinal chemistry. |
| 245 00 - TITLE STATEMENT |
|---|
| Title |
Foye's principles of medicinal chemistry. |
| 246 30 - VARYING FORM OF TITLE |
|---|
| Title proper/short title |
Principles of medicinal chemistry |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
Seventh edition. |
| 250 ## - EDITION STATEMENT |
|---|
| Edition statement |
International edition / |
| Remainder of edition statement |
edited by Thomas L. Lemke, PhD, David A. Williams, Phd ; associate editors, Victoria F. Roche, PhD, S. William Zito, PhD. |
| 260 ## - PUBLICATION, DISTRIBUTION, ETC. |
|---|
| Place of publication, distribution, etc. |
Philadelphia, PA : |
| Name of publisher, distributor, etc. |
Wolters Kluwer/Lippincott Williams & Wilkins, |
| Date of publication, distribution, etc. |
[2013] |
| 264 #1 - PRODUCTION, PUBLICATION, DISTRIBUTION, MANUFACTURE, AND COPYRIGHT NOTICE |
|---|
| Place of production, publication, distribution, manufacture |
Philadelphia : |
| Name of producer, publisher, distributor, manufacturer |
Wolters Kluwer, Lippincott Williams & Wilkins |
| Date of production, publication, distribution, manufacture, or copyright notice |
[2013] |
| 300 ## - PHYSICAL DESCRIPTION |
|---|
| Extent |
xviii, 1500 pages : |
| Other physical details |
illustrations (black and white) ; |
| Dimensions |
29 cm |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Includes Internet access. |
| 500 ## - GENERAL NOTE |
|---|
| General note |
Previous edition: published as by Thomas L. Lemke. Philadelphia, Pennsylvania: Lippincott Williams & Wilkins, 2008. |
| 504 ## - BIBLIOGRAPHY, ETC. NOTE |
|---|
| Bibliography, etc. note |
Includes bibliographical references and index. |
| 505 0# - FORMATTED CONTENTS NOTE |
|---|
| Formatted contents note |
History and evolution of medicinal chemistry -- Part I: Principles of drug discovery -- 1.Drug discovery from natural products. A. Douglas Kinghorn -- 2.Drug design and relationship of functional groups to pharmacologic activity. Robin M. Zavod and James J. Knittel -- 3.Physicochemical and biopharmaceutical properties of drug substances and pharmacokintics. Sunil S. Jambhekar -- 4.Drug metabolism. Davd A. Williams -- 5.Membrane drug transporters. Marilyn E. Morris and Bridget L. Morse -- 6.Pharmaceutical biotechnology. Tanaji T. Talele, Marc Gillespie, and Vijaya L. Korlipara -- 7.Receptors as targets for drug discovery. David A. Johnson and Timothy J. Maher -- 8.Drug discovery through enzyme inhibition. Stephen Kerr -- Part II: Drug receptors affecting neurotransmitters and enzymes as catalytic receptors -- 9.Drugs affecitng cholinergic neurotransmission. E. Kim Fifer -- 10.Andrenergic receptors and drugs affecting anrenergic neurotransmission. Robert K. Griffith -- 11.Serotonin receptors and drugs affecting serotonergic neurotransmission. Richard A. Glennon and Malgorzata Dukat -- 12.Amino acid neurotransmiters in the central nervous systems. Timothy J. Maher -- Part III.Pharmacodynamic agents. Section I: Drugs used to reat neuromuscular disorders: antiparkinsonian and spasmolytic agents. Raymond G. Booth - 14.Antipsychotic and anxiolytic drugs. Raymond G. Booth -- 15.Sedative-hynoptics. Nader H. Moniri -- 16.Anesthetic agents: general and local anesthetics. Timothy J. Maher -- 17.Antiseizure drugs. Barbara Leduc -- 18.Antidepressants. David A. Williams -- 19.Hallucinogenics, stimulants, and related drugs of abuse and their therapeutic potentials. Ricard A. Glennon -- 20.Central analgesics. David A. Williams, Victoria F. Roche, and Edward B. Roche -- Section 2: Drugs affecting the cardiovascular system -- 21.Cardiac agents: cardiac glycosides, antianginal, and antiarrhythmic drugs. Ahmed S. Mehanna -- 22.Diurectics. Peter J. Harvison and Gary O. Rankin -- -- 23.Agents affecting the renin-angiotensin pathway and calcium blockers. Marc Harrold -- 23.Central and peripheral sympatholytics and vasodilators. David A. Williams -- 25.Antihyperlipoproteinemics and inhibitors of cholesterol biosynthesis. Marc Harrold -- 26.Antithrombotics, thrombolytics, antiplatelets and coagulants. Matthias C. Lu -- Section 3: Drugs affecting the hormonal systmes -- 27.Insulin and drugs used to reat diabetes. S. William Zito -- 28.Adrenocorticoids. Duan D. Miller, Robert W. Brueggmeier, and James D. Dalton -- 29.Thyroid function and thyroid drugs. Ali R. Banijamali -- 30.Calcium homeostasis. Robin M. Zavod -- Section 4: Drugs affecting the immune system -- 31.Nonsteroidal anti-inlammatory drugs. Ronal Borne, Mark Levi, and Norman Wilson -- 32.Antihistamines and related antiallergic and antiucler agents. Wndell L. Nelson -- Section 5: Chemotherapeutic agents -- 33.Antibiotics and antimicrobial agents. Elmer J. Gentry -- 34.Antiparasitic agents. Thomas L. Lemke -- 35.Antifungal agents. Thomas L. Lemke -- 37.Cancer and chemotherapy. Victoria F. Roche -- 38.Antiviral agents and proteases inhibitors. Patrick M. Woster -- Part IV.Disease state management -- 39.Asthma and chronic obstructive pulmonary disease. S. William Zito -- 40.Men\'s health. Duane D. Miller, Robert W. Brueggmeier, and James T. Dalton -- 41.Women\'s health. Robin M. Zavod -- 43.Nutrition and obesity. Thomas L. Lemke and David A. Williams. |
| 520 8# - SUMMARY, ETC. |
|---|
| Summary, etc. |
This edition places emphasis on patient-focused pharmaceutical care and on the pharmacist as a therapeutic consultant, rather than a chemist. A new disease state management section explains appropriate therapeutic options for asthma, chronic obstructive pulmonary disease, and men's and women's health problems. |
| 650 #0 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical chemistry. |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Health and Wellbeing. |
| Source of heading or term |
ukslc |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmacology |
| Source of heading or term |
thema |
| 650 #7 - SUBJECT ADDED ENTRY--TOPICAL TERM |
|---|
| Topical term or geographic name entry element |
Pharmaceutical chemistry & technology |
| Source of heading or term |
thema |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lemke, Thomas L., |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Williams, David A., |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Roche, Victoria F., |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Zito, S. William, |
| Relator term |
editor of compilation. |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Lemke, Thomas L., |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Williams, David A., |
| Dates associated with a name |
1938- |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Roche, Victoria F., |
| Relator term |
editor |
| 700 1# - ADDED ENTRY--PERSONAL NAME |
|---|
| Personal name |
Zito, S. William, |
| Relator term |
editor |
| 902 ## - LOCAL DATA ELEMENT B, LDB (RLIN) |
|---|
| a |
170814 |
| 907 ## - LOCAL DATA ELEMENT G, LDG (RLIN) |
|---|
| a |
.b11738455 |
| b |
main |
| c |
- |
| 942 ## - ADDED ENTRY ELEMENTS (KOHA) |
|---|
| Suppress in OPAC |
0 |
| 960 ## - PHYSICAL LOCATION (RLIN) |
|---|
| Physical location, PLOC (RLIN) |
main |
| Copies |
2 |
| Cataloging date |
150908 |
| Code1 |
- |
| Code2 |
- |
| Code3 |
- |
| Code4 |
- |
| Acquisition type - method of paying for the material |
p |
| Claim – claiming activity |
- |
| Estimated price |
104.48 |
| Form – physical form |
b |
| Fund |
lps |
| Order date |
2015-07-02 |
| Order note |
- |
| Order type |
f |
| Receiving action |
- |
| Received date |
2015-08-18 |
| Receiving location |
a |
| Billing location |
q |
| Status |
a |
| Temporary shelving location |
p |
| Vendor |
bookn |
| Language |
eng |
| Country |
ie |
| Volumes |
0 |
| Millennium order record number |
.o10124482 |
| 961 ## - REQUESTOR & SELECTOR |
|---|
| Selector |
J Roche |
| -- |
Order printed 03-07-2015 12:26 |
| -- |
Order printed 10-08-2015 15:01 |
| Locations |
main |
| Funds |
lps |
| 998 ## - LOCAL CONTROL INFORMATION (RLIN) |
|---|
| Operator's initials, OID (RLIN) |
0 |
| Cataloger's initials, CIN (RLIN) |
150702 |
| First Date, FD (RLIN) |
m |
| Local |
a |
| -- |
- |
| -- |
0 |